Abstract: Introduction: The clinical presentation of COVID-19 varies from asymptomatic to severe complications, raising concerns about transmission risks and maternal- fetal outcomes in pregnant women. This study describes the clinical manifestations and management of severe SARS-CoV-2 infections in pregnancy.
Methods: A retrospective descriptive study was conducted at Menzel Temime Regional Hospital, Tunisia, from January to August 2021, including seven pregnant women with severe SARS-CoV-2 infection. Data on clinical presentation, diagnostic findings, treatment, and maternal-neonatal outcomes were collected from medical records.
Results: All cases presented in the third trimester with pneumonitis, with 71.4% classified as moderate to severe and 28.6% as critical. Fever (71.4%), cough (57.1%), and lymphopenia (71.4%) were common. Cesarean delivery was performed in 57.1% of cases. Three newborns tested positive for SARS-CoV-2, requiring pediatric hospitalization for respiratory distress, with no neonatal deaths. One maternal death occurred due to multi-organ failure. All patients received oxygen, antibiotics, corticosteroids, and anticoagulants, with one requiring mechanical ventilation.
Conclusion: Management of severe COVID-19 in pregnancy aligns with general population protocols, emphasizing multidisciplinary care. Vertical transmission appears rare, with minimal neonatal impact. Enhanced screening and preventive measures are crucial to reduce maternal morbidity.
Indexed in Index Copernicus
